Stock comparison
HealthEquity
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HQY
HealthEquity
Market cap
$7.39B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HQY | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 64D | 75B | IDXX |
| Benjamin Graham | 69D | 80A | IDXX |
| Philip Fisher | 63C | 75B | IDXX |
| Peter Lynch | 60C | 71B | IDXX |
| Joel Greenblatt | 42D | 83C | IDXX |
| Charlie Munger | 59D | 87A | IDXX |
| Terry Smith | 62D | 84A | IDXX |
Side-by-side metrics
| Metric | HQY | IDXX |
|---|---|---|
| Market cap | $7.39B | $44.12B |
| P/E (TTM) | 32.7x | 39.0x |
| EV/EBIT | 23.5x | 31.6x |
| ROIC (TTM) | 7.61% | 40.66% |
| Gross margin | 69.52% | 62.05% |
| Net margin | 16.38% | 24.63% |
| Revenue CAGR 5y | 14.79% | 7.56% |
| EPS CAGR 5y | - | 10.79% |
| Debt / Equity | 0.5x | 0.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HQY leads on
- Revenue CAGR 5y14.79%vs 7.56%+49%
- Debt / Equity0.5xvs 0.7x+31%
- EV/EBIT23.5xvs 31.6x+26%
- P/E (TTM)32.7xvs 39.0x+16%
IDXX leads on
- Market cap$44.12Bvs $7.39B+83%
- ROIC (TTM)40.66%vs 7.61%+81%
- Net margin24.63%vs 16.38%+33%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.